Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression.

@article{Parkhurst2011AdoptiveTO,
  title={Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression.},
  author={Maria R. Parkhurst and John Paul Riley and Mark Edward Dudley and Steven A Rosenberg},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2011},
  volume={17 19},
  pages={
          6287-97
        }
}
PURPOSE Adoptive transfer of tumor-infiltrating lymphocytes (TIL) can mediate regression of metastatic melanoma. However, many patients with cancer are ineligible for such treatment because their TIL do not expand sufficiently or because their tumors have lost expression of antigens and/or MHC molecules. Natural killer (NK) cells are large granular lymphocytes that lyse tumor cells in a non-MHC-restricted manner. Therefore, we initiated in a clinical trial to evaluate the efficacy of adoptively… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 141 CITATIONS, ESTIMATED 42% COVERAGE

Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation

  • Front. Immunol.
  • 2017
VIEW 12 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Adoptive Cellular Therapy (ACT) for Cancer Treatment.

  • Advances in experimental medicine and biology
  • 2016
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities

Weilei Hu, Guosheng Wang, Dongsheng Huang, Meihua Sui, Yibing Xu
  • Front. Immunol.
  • 2019

FILTER CITATIONS BY YEAR

2012
2019

CITATION STATISTICS

  • 7 Highly Influenced Citations

  • Averaged 22 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 35 REFERENCES

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2008
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…